Tag: Alzheimer
Lilly drug clearly works in early-stage Alzheimer’s patients
US pharmaceutical company Eli Lilly The data underscores that earlier detection and diagnosis can really change the course of Alzheimer’s, said Anne White, Lilly’s board member, responsible for neuroscience. (Photo:…
Leqembi fully approved in the US for the first time
Frankfurt The US Food and Drug Administration (FDA) has granted full approval for the first time for a therapy that slows the progression of Alzheimer’s disease. This was announced by…
FDA grants preliminary approval for new Alzheimer’s drug
Frankfurt On Friday evening, the American drug agency FDA granted preliminary approval for the new Alzheimer’s drug lecanemab, thereby raising hopes for further progress in the fight against dementia. The…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Roche’s Alzheimer’s drug disappoints in clinical trials
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The Swiss pharmaceutical giant Roche has to cope with another research setback with a new Alzheimer’s…
New data from drug research expected in autumn
Alzheimer’s disease Protein deposits in the brain – so-called amyloid plaques – are one of the main characteristics of Alzheimer’s disease. Many of the drug candidates currently being researched aim…
Alzheimer’s researcher Sylvain Lesné under suspicion of forgery
Frankfurt When Sylvain Lesné published a widely acclaimed study on a possible central cause of Alzheimer’s disease in the journal “Nature” 16 years ago, he, the main author, was just…
“Germany needs a 10 trillion euro state fund for start-ups”
Berlin The federal government’s “future fund” launched in 2021 to finance start-ups must grow from ten billion to ten trillion euros over the next 20 to 30 years. This is…
Eli Lilly is the new star of the pharmaceutical industry
Frankfurt In the past two years, the headlines in the pharmaceutical industry have been dominated by the American industry leader Pfizer with its Covid vaccine Comirnaty – developed together with…
Biogen Withdraws Marketing Authorization Application for Alzheimer’s Drug in Europe
biogenic After the rejection by the EMA, the pharmaceutical company submitted an application for review. However, it is now withdrawing the application for market approval. (Photo: Reuters) Bangalore The US…
So it is with the new Alzheimer’s therapy
Neurologist Alois Alzheimer, drug Aduhelm To date, there is no drug that can cure the disease. (Photo: Mauritius Images, Getty Images, REUTERS (M)) Frankfurt “Will there be a breakthrough in…
New study – researchers want to cure inflammation with the brain – guide
This could be a new step in the treatment of psychosomatic complaints. Israeli scientists have found out how the brain can make the body sick and how changes there could…